Research Article
Hepatitis B Infection and Mother-to-Child Transmission in Haiphong, Vietnam: A Cohort Study with Implications for Interventions
Table 3
Factors associated with infant’s HBV infection at 12-month follow-up (
).
| Infant’s characteristics | Infant with positive HBsAg, (%) | Crude ORa, OR [95% CI] | Adjusted ORb, OR [95% CI] | valuec |
| Mother’s HBeAg status at delivery | HBeAg (-) | 2 (1.7) | Ref. | Ref. | <0.001 | HBeAg (+) | 10 (34.5) | 31.3 [6.4-154.1] | 65.8 [7.3-594.1] |
| Mother’s HBV DNA level at delivery | <200,000 IU/mL (106 copies/mL) | 11 (7.6) | Ref. | | | ≥200,000 IU/mL (106 copies/mL) | 1 (16.7) | 2.4 [0.3-22.6] |
| Mother’s HBV peripartum antiviral therapy | Yes | 1 (3.4) | Ref. | | | No | 11 (9.1) | 2.8 [0.3-22.6] |
| Having any family members infected with HBVd | No | 7 (5.5) | Ref. | Ref. | 0.119 | Yes | 5 (21.7) | 4.8 [1.4-16.6] | 4.0 [0.7-23.4] |
| Mode of delivery | Vaginal | 8 (8.0) | Ref. | | | Caesarean | 4 (8.0) | 1.0 [0.3-3.5] |
| Infant’s sex | Female | 7 (9.7) | Ref. | | | Male | 5 (6.4) | 1.6 [0.5-5.2] |
| Infant’s HBV birth dose vaccination | Yes | 11 (7.4) | Ref. | Ref. | 0.057 | No | 1 (50.0) | 12.5 [0.7-212.9] | 36.1 [0.9-1459.5] |
| Infant’s HBIG immunization | Yes | 7 (5.7) | Ref. | Ref. | 0.181 | No | 5 (18.5) | 3.8 [1.1-12.9] | 3.4 [0.6-19.9] |
| Infant’s scheduled HBV vaccination | Completed | 10 (7.0) | Ref. | Ref. | 0.593 | Uncompleted | 2 (25.0) | 4.4 [0.8-24.7] | 2.1 [0.1-31.2] |
| Infant feeding (during 12 months of age) | Breast-fed only | 4 (8.5) | Ref. | | | Bottle-fed (and/or other food) | 3 (5.8) | 0.7 [0.1-3.1] | Mixed (breast-fed+bottle-fed and/or other food) | 5 (9.8) | 1.2 [0.3-4.6] |
|
|
aUnivariate analysis; bmultiple logistic regression; clikelihood-ratio test; dincluding infant’s father HBV infection status. OR: odds ratio; CI: confidence interval. . |